3-Hydroxyisoindolin-1-one derivates: Synthesis by palladium-catalyzed CH activation as BRD4 inhibitors against human acute myeloid leukemia (AML) cells.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);催化作用(Catalysis);细胞周期蛋白质类(Cell Cycle Proteins);细胞增殖(Cell Proliferation);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);分子结构(Molecular Structure);钯(Palladium);苯邻二甲酰亚胺类(Phthalimides);构效关系(Structure-Activity Relationship);转录因子(Transcription Factors);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1016/j.bioorg.2019.01.034
PMID
30690335
发布时间
2020-03-31
- 浏览15
Bioorganic chemistry
119-125页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文